Ravulizumab

From WikiMD.org
Jump to navigation Jump to search
Ravulizumab
TermRavulizumab
Short definitionravulizumab - (pronounced) (RAV-yoo-LIZ-yoo-mab) A medicine used to treat adults with paroxysmal nocturnal hemoglobinuria (a rare disease affecting red blood cells) and adults and children from 1 month of age with atypical haemolytic uremic syndrome (a very rare disease in which tiny blood clots form in small blood vessels). It is also being studied in the treatment of other conditions. 
TypeCancer terms
SpecialtyOncology
LanguageEnglish
SourceNCI
Comments


ravulizumab - (pronounced) (RAV-yoo-LIZ-yoo-mab) A medicine used to treat adults with paroxysmal nocturnal hemoglobinuria (a rare disease affecting red blood cells) and adults and children from 1 month of age with atypical haemolytic uremic syndrome (a very rare disease in which tiny blood clots form in small blood vessels). It is also being studied in the treatment of other conditions. Ravulizumab attaches to a protein in the immune system called C5. This can help prevent the breakdown of red blood cells and the formation of blood clots. Ravulizumab is a type of monoclonal antibody. Also called Ultomiris

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski